The EPSRC funding for the IRC, £10m over six years, enables a longer-term, interdisciplinary research programme which comprises 18 principal investigators working across five founding universities, Cambridge, Imperial, UCL, Glasgow, Birmingham and, more recently, Nottingham. Our shared aim is to develop and validate drug-delivery technologies to support the work of clinicians and improve survival rates for patients.
Director
Professor George Malliaras
Director of the IRC and Prince Philip Professor of Technology,
University of Cambridge
InvestigatorsProfessor Cameron Alexander Dr Ronan Daly Dr David Fairen-Jimenez Professor Ross Forgan Dr Ljiljana Fruk Professor Simon Gaisford Professor Rylie Green Dr Su Metcalfe Dr Ruman Rahman Professor Oren Scherman Dr Yan Yan Shery Huang |
Clinical LeadsProfessor Richard Gilbertson Professor Duncan Jodrell Professor Stefan Marciniak Professor Colin Watts Core TeamDr Amanda Fuller Kirsty Shepherd Dr Simone Castello Lisa Millard |